Funding for this research was provided by:
National Human Genome Research Institute (ZIAHG200335, ZIAHG200335, ZIAHG200335, ZIAHG200335, ZIAHG200378, ZIAHG200335)
National Institute of Mental Health
National Institute on Drug Abuse (ZIADA000628)
National Institutes of Health Office of Behavioral and Social Science Research
National Institutes of Health
Received: 16 February 2022
Accepted: 31 August 2022
First Online: 20 September 2022
: The IRB at University of Pennsylvania determined that the study was exempt from review. All research was performed in accordance with relevant guidelines and regulations. Online written consent was obtained from all participants prior to beginning the survey.
: Not applicable.